DexCom Non-GAAP EPS of $0.32 misses by $0.20, revenue of $628.8M beats by $4.83M
DexCom press release  (NASDAQ:DXCM): Q1  Non-GAAP EPS of $0.32  misses by $0.20.
Revenue of $628.8M (+24.5% Y/Y)  beats by $4.83M.
Outlook: The company is reiterating guidance for fiscal year 2022:Â Revenue expected to be in the range of approximately $2.82 - 2.94 billion (15-20% growth), vs. consensus of $2.92B

Non-GAAP Gross Profit Margin of approximately 65%
Non-GAAP Operating Margin of approximately 16%
Adjusted EBITDA Margin of approximately 25%